Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Cancer. 2015 Dec 22;122(5):758–765. doi: 10.1002/cncr.29824

Figure 4.

Figure 4

Patients with liver-only disease who underwent treatment with Hepatic Arterial Infusion (HAI) and Systemic (SYS) Chemotherapy (N=78) had an improved survival compared to those who were treated only with Systemic Chemotherapy (N=26) (30.8 months vs 18.4 months, respectively; p<0.001)